At first, Krista Easom figured the little red bump on her foot was nothing more than a blister.
It didn’t hurt, but after a couple months, it didn’t go away either.
She booked an appointment with a dermatologist to have it removed. She wasn’t worried. Easom, a 24-year-old law school student from New Jersey, was healthy, had no family history of cancer and was getting ready to enjoy some time in her newly adopted city of Chicago.
That’s when she received the results from her dermatologist, who removed a part of the blister and had it tested.
It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It’s a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.
Further tests revealed that Easom’s melanoma had spread to her lymph nodes, which meant she needed a lymphadenectomy to have them removed. This major surgery includes a five-day stay in the hospital followed by an extensive recovery. About half of the patients who undergo this procedure suffer from wound infections because of the 12-inch incision’s hip-to-thigh location.
Easom and her family looked into her options and she was referred to Northwestern Medicine® surgical oncologists Jeffery D. Wayne, MD and Karl Bilimoria, MD, two of the very few surgeons in the country using a minimally invasive procedure to remove groin lymph nodes. This laparoscopic procedure may drastically reduce the recovery rate and chance of infection for patients like Easom.
“Only a handful of surgeons in the country are doing this and it makes a world of difference to the patient,” said Bilimoria, a surgical oncologist at Northwestern Memorial Hospital and an assistant professor of surgery at Northwestern University Feinberg School of Medicine. “Instead of a 12-inch scar, this laparoscopic procedure has only three very small incisions that total less than one inch. Because these incisions are so small, the chance of infection is far less. Instead of a five-day stay in the hospital, Krista went home the day after her surgery.”
Lymph nodes are the most frequent site of the spread of metastatic melanoma and surgically removing them is the only potential for a cure, Wayne said.
“Surgery is the only way to make sure we get all of the cancer,” Wayne said. “We want Krista to move on with her life. The minimally-invasive procedure was by far, the quickest and safest way for her to do that.”
Just a few weeks post-surgery, Easom is already on her way. She will have regular check-ups for awhile but her CT scans and blood tests show that the surgery successfully removed all of her cancer. Easom is participating in a national clinical trial to see if this minimally invasive procedure can help other melanoma patients.
The Latest on: Melanoma
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaon December 2, 2019 at 8:22 am
In this study, we analyzed a clinically annotated cohort of patients with melanoma (n = 144) treated with anti-PD1 ICB, with whole-exome and whole-transcriptome sequencing of pre-treatment tumors. We ...
- Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patientson December 2, 2019 at 2:20 am
The purpose was to evaluate the potential of diffusion-weighted-magnetic resonance imaging (DW-MRI) and 18 F-fludeoxy-glucose-positron emission tomography integrated with CT (FDG-PET/CT) for ...
- Approaches to Stage II and III Melanoma: Recent Research Contexton December 1, 2019 at 12:52 am
This paper explores an important and topical question in melanoma management: what is the role for adjuvant therapy in resected stage II and III melanoma? Targeted therapy and immune checkpoint ...
- Melanoma Treatment Market Augment Growth with Notable CAGR by 2026on November 24, 2019 at 10:19 pm
Nov 25, 2019 (Heraldkeepers) -- The cancer of melanocytes-- a type of pigment cells - is known as melanoma. A major factor causing this skin cancer is high exposure to ultraviolet rays. There are ...
- Rihanna's Fenty Beauty Model Slick Woods Is Undergoing Chemotherapy For Stage 3 Melanoma — What We Knowon November 24, 2019 at 2:27 pm
She's our newest she-ro! Who is Slick Woods and how is she doing? That's the question that everyone has been asking since the model and actress announced that she was diagnosed with Stage 3 melanoma.
- Fenty Model Slick Woods Reveals Stage 3 Melanoma Diagnosis—Here's What That Meanson November 22, 2019 at 10:49 am
After years of addiction, a Louisiana man got an implant while in prison to help fight his opioid cravings. He says it changed his life. Meg Farris of WWL-TV reports from New Orleans. CBS News Many ...
- RDK Melanoma Foundation: Keeping public safe from sunon November 21, 2019 at 11:55 am
What does the Richard David Kann Melanoma Foundation do? The Richard David Kann (RDK) Melanoma Foundation has been working locally and nationally since its inception to save lives by changing ...
- Rochester cancer-therapy firm to collaborate with drugmaker on melanoma treatmenton November 21, 2019 at 9:25 am
Vyriad, a company in southeastern Minnesota that is designing viruses to selectively kill cancer cells, has signed a major agreement with the biotech drugmaker Regeneron to collaborate on drug ...
- How much sunshine causes melanoma? It's in your geneson November 21, 2019 at 6:46 am
Australian researchers from QIMR Berghofer Medical Research Institute have shown that 22 different genes help to determine how much sun exposure a person needs to receive before developing melanoma.
- Rochester cancer therapy firm to collaborate with drugment on melanoma treatmenton November 20, 2019 at 10:23 am
Vyriad, a company in southeastern Minnesota that is designing viruses to selectively kill cancer cells, has signed a major agreement with the biotech drugmaker Regeneron to collaborate on a drug ...
via Google News and Bing News